EV/EBITDA
-3.76
-0.28-8.05%
3 min ago
Summary:
Cardiol Therapeutics EV/EBITDA is currently -3.76, with a fall of -0.28 (-8.05%) during the most recent trading day. Over the past year, it has dropped by -2.39 (-174.45%). CRDL EV/EBITDA is now -917.39% below its all-time high of 0.46.CRDL EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRDL EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -8.1% |
| 1 m1 month | +24.4% |
| 3 m3 months | +35.7% |
| 6 m6 months | +28.5% |
| ytdytd | -205.7% |
| 1 y1 year | -174.4% |
| 5 y5 years | +49.8% |
CRDL EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -3.45 | -9.0% | -5.12 | +26.6% |
| 3 m | 3 months | -3.45 | -9.0% | -6.30 | +40.3% |
| 6 m | 6 months | -3.45 | -9.0% | -6.66 | +43.5% |
| 1 y | 1 year | -1.22 | -208.2% | -8.40 | +55.2% |
| 3 y | 3 years | 0.46 | -917.4% | -8.40 | +55.2% |
| 5 y | 5 years | 0.46 | -917.4% | -8.71 | +56.8% |
| alltime | all time | 0.46 | -917.4% | -11.35 | +66.9% |
Cardiol Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -3.76(+205.7%) |
| 2023 | -1.23(-451.4%) |
| 2022 | 0.35(-121.9%) |
| Date | Value |
|---|---|
| 2021 | -1.60(-59.5%) |
| 2020 | -3.95(-53.4%) |
| 2019 | -8.47 |
FAQ
- What is Cardiol Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Cardiol Therapeutics?
- What is CRDL EV/EBITDA year-to-date change?
- What is Cardiol Therapeutics EV/EBITDA year-on-year change?
What is Cardiol Therapeutics EV/EBITDA?
The current EV/EBITDA of CRDL is -3.76
What is the all time high EV/EBITDA for Cardiol Therapeutics?
Cardiol Therapeutics all-time high EV/EBITDA is 0.46
What is CRDL EV/EBITDA year-to-date change?
Cardiol Therapeutics EV/EBITDA has changed by -2.53 (-205.69%) since the beginning of the year
What is Cardiol Therapeutics EV/EBITDA year-on-year change?
Over the past year, CRDL EV/EBITDA has changed by -2.39 (-174.45%)